Veritable, L.P. Vincerx Pharma, Inc. Transaction History
Veritable, L.P.
- $0
- Q3 2023
Shares
2 transactions
Others Institutions Holding VINC
# of Institutions
29Shares Held
10.7MCall Options Held
0Put Options Held
0-
Prosight Management, LP Dallas, TX2.49MShares$1.69 Million0.63% of portfolio
-
Armistice Capital, LLC New York, NY1.99MShares$1.35 Million0.02% of portfolio
-
Sage Rhino Capital LLC1.7MShares$1.16 Million0.34% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$606,3680.02% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct674KShares$458,4510.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $14.4M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...